Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

January 31, 2006

Conditions
Leukemia, Lymphoblastic, Acute, Pediatric
Interventions
DRUG

clofarabine (IV formulation)

Trial Locations (14)

15213

Children's Hospital, Pittsburgh

60614

Children's Memorial Hospital, Chicago

76104

Cook's Children's Medical Center, Fort Worth

80218

Children's Hospital, Denver

90027

Children's Hospital, Los Angeles

Unknown

Children's Hospital, Orange County

Children's Hospital, San Diego

Johns Hopkins Children's Center, Baltimore

Children's Hospital, St Louis

Memorial Sloan-Kettering, New York

Children's Hospital, Philadelphia

St. Jude Children's Research Hospital, Memphis

Texas Children's Cancer Center, Houston

The University of Texas M.D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00042341 - Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) | Biotech Hunter | Biotech Hunter